TSPEAR, an acronym for Thrombospondin Type Laminin G Domain and EAR Repeats, refers to a protein encoded by the TSPEAR gene, which is expressed in various tissues throughout the human body. The protein plays a pivotal role in cell-cell communication and adhesion, processes that are fundamental to the maintenance and development of multicellular organisms. The TSPEAR protein's structure, which includes thrombospondin and laminin G domains, suggests it has a significant role in the extracellular matrix, contributing to tissue integrity and possibly signaling pathways essential for cellular differentiation and morphogenesis. Given the relevance of TSPEAR in such critical biological processes, the regulation of its expression is a focal point of interest in the field of molecular biology. The expression of TSPEAR is tightly controlled by a complex network of transcription factors and epigenetic modifications that can be influenced by various internal and external stimuli.
Research into the regulation of TSPEAR has led to the identification of several chemical compounds that show potential in inhibiting its expression. These inhibitors could act directly on the TSPEAR gene itself or indirectly by altering the cellular environment that controls TSPEAR expression. For example, certain inhibitors may interfere with the DNA methylation patterns that are crucial for the gene's transcriptional activity, leading to a reduction in TSPEAR expression. Other compounds might inhibit histone deacetylases, enzymes that modify chromatin structure and thus play a key role in gene expression; such inhibition could result in changes to the chromatin landscape surrounding the TSPEAR gene, leading to its decreased transcription. Moreover, some chemicals have the potential to disrupt signaling pathways that indirectly modulate the expression of TSPEAR, providing additional layers of control over its production. While the exploration of these inhibitors is ongoing, understanding their interaction with the TSPEAR gene and its regulatory mechanisms offers valuable insight into the complex dynamics of gene expression regulation in human cells.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By incorporating into DNA, 5-Azacytidine may cause demethylation at the TSPEAR gene promoter, resulting in the downregulation of TSPEAR transcription. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
This compound inhibits histone deacetylase activity, which can lead to a less condensed chromatin state at the TSPEAR locus, decreasing its transcription. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
As an mTOR pathway inhibitor, Rapamycin may reduce TSPEAR expression by attenuating the translation control exerted by this growth signaling pathway. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY 294002 inhibits PI3K, which could lead to reduced phosphorylation of Akt and a subsequent decrease in transcription factors necessary for TSPEAR expression. | ||||||
Spironolactone | 52-01-7 | sc-204294 | 50 mg | $109.00 | 3 | |
Spironolactone might decrease TSPEAR expression by blocking androgen receptors, which may be involved in the transcriptional activation of the TSPEAR gene. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate may inhibit the expression of TSPEAR by reducing the pool of nucleotides necessary for the gene's transcription, due to its action on dihydrofolate reductase. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $218.00 $322.00 $426.00 | 7 | |
5-Aza-2′-Deoxycytidine can lead to DNA demethylation, which might specifically reduce methylation at the TSPEAR gene locus, resulting in decreased expression. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
By activating sirtuins, Resveratrol could deacetylate histones at the TSPEAR gene, leading to chromatin remodeling and a reduction in TSPEAR mRNA synthesis. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea could inhibit ribonucleotide reductase, limiting DNA synthesis during the S phase of the cell cycle and potentially decreasing TSPEAR expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
This proteasome inhibitor could disrupt the degradation of transcriptional repressors of the TSPEAR gene, leading to reduced expression levels. | ||||||